trial · primary record
Itraconazole 65 MG
Bronchiectasis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-12-31 |
| Primary endpoint | frequency of bronchiectasis exacerbations during the study period |
| Registry ID | NCT06160713 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:28.680Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06160713
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.